Do you think that your technology or research would be complementary to ours?
Arquer Diagnostics maintain a policy of active collaboration with companies, research groups and clinicians
Arquer is interested opportunities for in-licencing cancer biomarkers or technologies where there is a fit with its current platform and products.
Arquer Diagnostics assay platform is readily adaptable for the detection of other cancer biomarkers and therefore can provide a rapid route to market based on proven technology.
If your business, university department or other scientific or medical organisation has cancer biomarkers or technologies that might be suitable licensing candidates please get in touch.
Do you have a clinical trial or a sampling device that may be compatible with Arquer Diagnostics Technology? If you are interested in collaborating with Arquer in the development of a cancer diagnostic, please get in touch.